---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-006890"
form_type: "8-K"
ticker: "AWHL"
cik: "0000926617"
company_name: "Aspira Women's Health Inc."
filed_at: "2025-02-14T23:59:59+00:00"
generated_at: "2026-05-26T21:51:43.767219+00:00"
event_type: "regulatory"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Aspira Women's Health resolves Nasdaq listing violation by amending warrants; compliance regained but risk remains

## Summary
- Received Nasdaq notice Feb 11, 2025 for violating Rule 5635(c) by issuing shares/warrants below market value without shareholder approval.
- Amended warrants same day to prohibit exercise until shareholder approval, regaining compliance with Nasdaq.
- Private placement involved 1,264,739 shares and warrants at $1.53/unit; market value per unit was $1.595.
- Company cautions there is no guarantee its common stock will remain listed on Nasdaq Capital Market.

## SEC filing metadata
- accession: 0001493152-25-006890
- form_type: 8-K
- ticker: AWHL
- cik: 0000926617
- company_name: Aspira Women's Health Inc.
- filed_at: 2025-02-14T23:59:59+00:00
- event_type: regulatory
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/926617/000149315225006890/0001493152-25-006890-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/926617/000149315225006890/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-006890
- JSON: https://secwatch.observer/filing/0001493152-25-006890.json
- Plain text: https://secwatch.observer/filing/0001493152-25-006890.txt

## Source-grounded claims
- claim_id: 0642dd67539bcc1f8c001fa8490a0717e184b437
  claim: Aspira Women's Health Inc. received a nasdaq deficiency notice notice regarding shareholders (rules 5635(c)).
  evidence_excerpt: February 11, 2025, the Company received written notice (the “Notice”) from the Nasdaq Stock Market, LLC (“Nasdaq”) that based on the closing bid price per share immediately preceding entering into a binding agreement to
  evidence_url: https://www.sec.gov/Archives/edgar/data/926617/000149315225006890/0001493152-25-006890-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.